Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
284 results
  1. MedlinePlus Drug Information: L-glutamine 
    https://medlineplus.gov/druginfo/meds/a617035.html
    L-glutamine is used to is used to reduce the frequency of painful episodes (crises) in adults and children ... oxygen to all parts of the body). L-glutamine is in a class of medications called amino ...
  2. Topics in Integrative, Alternative, and Complementary Therapies (PDQ®) - PDQ Cancer Information Summaries - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK126745
    ... summary on the Gerson Therapy for more information. Glutamine Glutamine is an amino acid that is important for ... quality of life. Some evidence suggests that oral glutamine can reduce both of those toxicities by aiding ...
  3. Sickle Cell Disease - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1377
    ... 2010 , Strouse & Heeney 2012 , Yawn et al 2014 ]. Glutamine has just received FDA approval for the prevention ... to its antioxidant properties and in vitro activity, glutamine has long been considered of potential benefit in ...
  4. Nutrition in Cancer Care (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66004
    ... does not appear to have side effects. Oral glutamine Oral glutamine is an amino acid that is being studied ... sores) caused by chemotherapy or radiation therapy. Oral glutamine may help prevent mucositis or make it less ...
  5. NLM Digital Collections - Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease : effectiveness and value 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, March 12, 2020
    resource.nlm.nih.gov/101769581
    Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease : effectiveness and value ... Glutamine -- therapeutic use ... have gained regulatory approval in the US. L-glutamine (Emmaus) is a precursor of nucleic acids and ...
  6. xmlghr-summaries.xml 
    https://medlineplus.gov/download/ghr-summaries.xml
    ... gene-symbol >ASNS</gene-symbol><name >asparagine synthetase (glutamine-hydrolyzing)</name><ghr-page >https://medlineplus.gov/genetics/ ... the amino acid asparagine. Another amino acid called glutamine helps in the conversion and is itself converted ...
  7. Results - Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis - .... 
    https://www.ncbi.nlm.nih.gov/books/NBK61949
    ... LBM in patients receiving rhGH and who received glutamine therapy. Four markers of protein turnover were evaluated ... and 1 trial compared rhGH alone to either glutamine or the combination of glutamine and rhGH. 30 ...
  8. Spinocerebellar Ataxia Type 2 - GeneReviews® - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK1275
    ... size because both CAG and CAA code for glutamine [ Costanzi-Porrini et al 2000 ]; however, the interruption ... repeat interruptions. Because the CAA codon also encodes glutamine, these interruptions do not interrupt the glutamine tract ...
  9. 2019New_Mesh_Tree_Hierarchy.txt 
    https://www.nlm.nih.gov/.../download/2019New_Mesh_Tree_Hierarchy.txt
    ... 811.464.259.400 Carbon-Nitrogen Ligases with Glutamine as Amide-N- Donor D08.811.464.259.400.300 Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzin g) D08.811.464.259.550 Formate- ...
  10. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Carbamoyl-Phosphate Synthase (Ammonia) Carbon-Nitrogen Ligases with Glutamine as Amide-N Carbamoyl-Phosphate Synthase (Glutamine Formate-Tetrahydrofolate Ligase Peptide Synthases Glutamate-Cysteine Ligase ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last